Related Experiment Video
Updated: Nov 25, 2025

An Image Guided Transapical Mitral Valve Leaflet Puncture Model of Controlled Volume Overload from Mitral Regurgitation in the Rat
Published on: May 19, 2020
MAGGIC Risk Model Predicts Adverse Events and Left Ventricular Remodeling in Non-Ischemic Dilated Cardiomyopathy
Yang Dong1, Dongfei Wang1, Jialan Lv1
1Department of Cardiology, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
Insights
The Meta-analysis Global Group in Chronic Heart Failure (MAGGIC) risk score predicts adverse events and left ventricular remodeling in dilated cardiomyopathy patients. This score aids in assessing prognosis and understanding disease progression.
Area of Science:
- Cardiology
- Heart Failure Research
- Clinical Prognostics
Background:
- Dilated cardiomyopathy (DCM) is a significant cause of heart failure.
- Accurate prognostic models are crucial for managing DCM patients.
- Left ventricular remodeling is a key factor in DCM progression and outcomes.
Purpose of the Study:
- To evaluate the prognostic value of the Meta-analysis Global Group in Chronic Heart Failure (MAGGIC) risk score in patients with dilated cardiomyopathy.
- To investigate the relationship between the MAGGIC risk score and left ventricular remodeling in DCM.
Main Methods:
- Prospective study of 114 DCM patients with clinical assessments and echocardiography.
- MAGGIC risk score calculation and follow-up for adverse events (mortality, heart failure rehospitalization).
- Assessment of left ventricular remodeling and statistical analysis using Cox regression and ROC curves.
Main Results:
- The MAGGIC risk score independently predicted adverse events, including all-cause mortality and heart failure rehospitalization.
- A significant correlation was found between the MAGGIC risk score and changes in left ventricular remodeling parameters.
- The model showed modest discrimination for adverse events and left ventricular remodeling (AUC 0.6-0.7).
Conclusions:
- The MAGGIC risk score is associated with adverse clinical outcomes in dilated cardiomyopathy.
- The MAGGIC risk score also correlates with left ventricular remodeling, a marker of disease severity.
- This risk score can aid in predicting prognosis and monitoring disease progression in DCM.
Purpose:
We aimed to study the Meta-analysis Global Group in Chronic Heart Failure (MAGGIC) risk model's prognostic value and relationship with left ventricular remodeling in dilated cardiomyopathy.
Patients And Methods:
Dilated cardiomyopathy patients were prospectively recruited and underwent clinical assessments. MAGGIC risk score was calculated. Patients were followed up for adverse events and echocardiography. Primary endpoints were all-cause mortality and first rehospitalization due to heart failure. Secondary endpoint was left ventricular remodeling defined as a decline in left ventricular ejection fraction >10% or an increase in left ventricular end-diastolic diameter >10%. Survival status was examined using Cox regression analysis. The model's ability to discriminate adverse events and left ventricular remodeling was calculated using a receiver operating characteristics curve.
Results:
In total, 114 patients were included (median follow-up time = 31 months). The risk score was independently related to adverse events (2-year all-cause mortality: hazard ratio [HR] = 1.122; 95% confidence interval [CI], 1.043-1.208; 1-year first rehospitalization due to heart failure: HR = 1.094; 95% CI, 1.032-1.158; 2-year first rehospitalization due to heart failure: HR = 1.088; 95% CI, 1.033-1.147, all P < 0.05). One-year change in left ventricular end-diastolic diameter was correlated with the risk score (r = 0.305, P = 0.002). The model demonstrated modest ability in discriminating adverse events and left ventricular remodeling (all areas under the curve were 0.6-0.7).
Conclusion:
The MAGGIC risk score was related to adverse events and left ventricular remodeling in dilated cardiomyopathy.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Mitral Regurgitation I: Introduction

